VC  freeflow

https://www.freeflow.io/




     Office Locations:

1200 E California Blvd
Pasadena, CA 91125
 

Stages:

  • Seed
 

Industries:

  • Energy & Clean Tech
  • Food & Agriculture
  • Life Sciences & Healthcare
  • Medical Device


    		•
     

    Description:

    freeflow invests in seed-stage Caltech and JPL startups focused on sustainability, specifically human and planetary health. Investment focus areas include drug discovery and development tools and platforms, therapeutics, diagnostics, vaccines, medical devices, energy production, and storage, autonomous systems, food & agriculture, and new materials. About $35 million has been invested in Caltech and JPL startups, 27 companies overall.



    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
       
       
       
    COMPANY STAGEREVENUE
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)    		No Revenue
    Early StageMinimal
    Revenue
    Growth Stage
    (also called Mid-stage)    		$2M-$7M
    Expansion Stage
    (also called Late-stage)    		$7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B
       
       
     

    Investment Team:


    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription or Southern California Database subscription.
    David Fleck Founder & Managing Partner
    Fred Wilson Advisor
    Kevin Barrett Managing Partner

     

    Recent Funding Events (trailing 12 months):


      Date
      Name
      State
      Amount
      Stage

      10/03/2023
      Iambic Therapeutics
      CA
      $100,000,000
      Series B

     

    Portfolio companies include:


      Aralez Bio


      DNA Two


      Flion


      Iambic Therapeutics
        web link


      iuno


      Mango


      Membrion
        web link


      Pana Bio


      Stealth


      Stroke DX


     

    Recent News: